Ipriflavone Suppresses Growth of Esophageal Squamous Cell Carcinoma Through Inhibiting mTOR In Vitro and In Vivo

Ipriflavone, a synthetic isoflavone that inhibits osteoclastic bone resorption, has been used clinically for the treatment of osteoporosis. However, the anticancer activity of Ipriflavone and its molecular mechanisms in the context of esophageal squamous cell carcinoma (ESCC) have not been investiga...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Xiaodan, Zhang, Yuanyuan, Xie, Xiaomeng, Pang, Mengjun, Laster, Kyle, Li, Jian, Ma, Xinli, Liu, Kangdong, Dong, Zigang, Kim, Dong Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222593/
https://www.ncbi.nlm.nih.gov/pubmed/34178634
http://dx.doi.org/10.3389/fonc.2021.648809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222593/
https://www.ncbi.nlm.nih.gov/pubmed/34178634
http://dx.doi.org/10.3389/fonc.2021.648809

Ejemplares similares